Organon (OGN) Total Current Liabilities (2020 - 2026)
Organon (OGN) posted Total Current Liabilities of $2.6 billion for Q2 2026, up 4.64% on a QoQ basis from $2.5 billion in Q1 2026, and down 6.44% year-over-year from $2.8 billion in Q2 2025.
Analysis
Organon (OGN) Total Current Liabilities (2020 - 2026) Analysis & Trends
Organon has reported Total Current Liabilities for 7 years, with the latest figure at $2.6 billion in Q2 2026.
- On a quarterly basis, Total Current Liabilities fell 6.44% year-over-year to $2.6 billion in Q2 2026; TTM through Jun 2026 was $2.6 billion, a 6.44% decrease from a year earlier, with the FY2025 full-year figure at $2.4 billion, down 12.07% from the prior year.
- Total Current Liabilities was $2.6 billion for Q2 2026 at Organon, up from $2.5 billion in the prior quarter.
- The five-year high for Total Current Liabilities was $2.9 billion in Q4 2023, with the low at $2.3 billion in Q1 2022.
- Average Total Current Liabilities over 5 years is $2.6 billion, with a median of $2.5 billion recorded in 2022.
- The sharpest annual moves came in 2022 and 2023: Total Current Liabilities retreated 25.6% in 2022, then increased 16.16% in 2023.
- Over 5 years, Total Current Liabilities stood at $2.5 billion in 2022, then advanced by 16.16% to $2.9 billion in 2023, then decreased by 6.85% to $2.7 billion in 2024, then declined by 12.07% to $2.4 billion in 2025, then advanced by 9.46% to $2.6 billion in 2026.
- The last three Total Current Liabilities figures came in at $2.6 billion (Q2 2026), $2.5 billion (Q1 2026), and $2.4 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 54.90 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | 41.64 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | 27.73 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | 31.75 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | 32.65 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | 37.11 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | 354.06 Mn |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 1.31 Bn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 607.80 Mn |
| 10 | Organon | 3.58 Bn | 2.45 Bn | 847.00 Mn | 2.62 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.62 Bn |
| Mar 31, 2026 | 2.50 Bn |
| Dec 31, 2025 | 2.39 Bn |
| Sep 30, 2025 | 2.68 Bn |
| Jun 30, 2025 | 2.80 Bn |
| Mar 31, 2025 | 2.62 Bn |
| Dec 31, 2024 | 2.72 Bn |
| Sep 30, 2024 | 2.79 Bn |
| Jun 30, 2024 | 2.76 Bn |
| Mar 31, 2024 | 2.55 Bn |
| Dec 31, 2023 | 2.92 Bn |
| Sep 30, 2023 | 2.49 Bn |
| Jun 30, 2023 | 2.39 Bn |
| Mar 31, 2023 | 2.35 Bn |
| Dec 31, 2022 | 2.51 Bn |
| Sep 30, 2022 | 2.33 Bn |
| Jun 30, 2022 | 2.40 Bn |
| Mar 31, 2022 | 2.31 Bn |
| Dec 31, 2021 | 2.60 Bn |
| Sep 30, 2021 | 3.13 Bn |